Results 1 - 10 of 17 for nasal capsule within all areas of the EPA. Only web pages are included. Search all document formats.
Did you mean: nasal copiously ?

Show per page  
IRIS Summary of Methyl methacrylate (CASRN 80-62-6)01-28-2010
"This is a summary of information on Methyl methacrylate (CASRN 80-62-6) provided by the Integrated Risk Information System (IRIS)."
http://www.epa.gov/NCEA/iris/subst/1000.htm (HTML)
Methyl methacrylate (CASRN 80-62-6) | IRIS | US EPA01-28-2010
Methacrylate Producers Association (MPA) commissioned a reexamination of the nasal tissue block and a rereview of the histopathology of the rat nasal tissues from the Hazelton (1979a) study (Lomax, 1992; Lomax et ...
http://www.epa.gov/IRIS/subst/1000.htm (HTML)
Methyl methacrylate (CASRN 80-62-6) | IRIS | US EPA07-09-2009
Methacrylate Producers Association (MPA) commissioned a reexamination of the nasal tissue block and a rereview of the histopathology of the rat nasal tissues from the Hazelton (1979a) study (Lomax, 1992; Lomax et ...
http://www.epa.gov/ncea/iris/subst/1000.htm (HTML)
IRIS Summary on Acrolein (CASRN 107-02-8)01-28-2010
"This is a summary of infornation on Acrolein (CASRN 107-02-8) provided by the Integrated Risk Information System (IRIS)"
http://www.epa.gov/NCEA/iris/subst/0364.htm (HTML)
Acrolein (CASRN 107-02-8) | IRIS | US EPA01-28-2010
Abnormal breathing and nasal/eye discharge were among the clinical findings in high-dose ... 1992c) administered acrolein (0.1% aqueous) in gelatin capsules to beagle dogs, so the dose concentration to the glandular ...
http://www.epa.gov/IRIS/subst/0364.htm (HTML)
Acrolein (CASRN 107-02-8) | IRIS | US EPA07-09-2009
Abnormal breathing and nasal/eye discharge were among the clinical findings in high-dose ... 1992c) administered acrolein (0.1% aqueous) in gelatin capsules to beagle dogs, so the dose concentration to the glandular ...
http://www.epa.gov/ncea/iris/subst/0364.htm (HTML)
IRIS Summary of Chlorine dioxide (CASRN 10049-04-4)01-28-2010
"This is a summary of information on Chlorine dioxide (CASRN 10049-04-4) provided by the Integrated Risk Information System (IRIS)."
http://www.epa.gov/NCEA/iris/subst/0496.htm (HTML)
Chlorine dioxide (CASRN 10049-04-4) | IRIS | US EPA01-28-2010
Significant increases in incidence of nasal lesions (goblet cell hyperplasia and inflammation of nasal turbinates) were found in the exposed animals ...
http://www.epa.gov/IRIS/subst/0496.htm (HTML)
Chlorine dioxide (CASRN 10049-04-4) | IRIS | US EPA07-09-2009
Significant increases in incidence of nasal lesions (goblet cell hyperplasia and inflammation of nasal turbinates) were found in the exposed animals ...
http://www.epa.gov/ncea/iris/subst/0496.htm (HTML)
IRIS Summary of Dichlorvos (CASRN 62-73-7)01-21-2010
"This is a summary of information on Dichlorvos (CASRN 62-73-7) provided by the Integrated Risk Information System (IRIS)."
http://www.epa.gov/NCEA/iris/subst/0151.htm (HTML)

[Prev] 1 2 [Next]

Jump to main content.